Collaboration set to tackle chronic disease management in the UK
Anyone who has been following the development of the big data debate will understand that there is a huge opportunity to gain tangible benefits from the better use of data. One area that is awash with data is the healthcare sector, in particular the NHS. Imagine the opportunity if big data was applied here? But a challenge lies ahead to implement a change in mind-set and action. This could be the vital steps needed to help drive savings of £20bn a year by 2015.
The world Economic Forum highlighted that chronic care for high blood pressure (hypertension), vascular diseases like heart disease and strokes, lung diseases like asthma and COPD and endocrine diseases like diabetes, could cost $47 trillion by 2030. With 80% of healthcare budgets being spent on tackling this, action needs to be taken. One step towards this is the recently announced strategic partnership between health and biomedical informatics company Aridhia and big data analytics expert Pivotal.
The partnership aims to take the lead on big data, creating a new technology platform capable of revolutionising the management of chronic health conditions such as cancer, diabetes and cardiovascular disease. This can only be a positive step for the NHS, which has already laid the big data foundations by using analytics within NHS Blood and Transplant to improve patient survival rates.
According to our research of senior business and public sector leaders, to coincide with the launch of an EMC-supported Policy Exchange report, public sector leaders recognise that big data can help make an impact in the area of patient care and outcomes (65%). Therefore, big data industry developments like the Aridhia announcement is a step in the right direction as the collaboration makes its easier for the NHS and private healthcare organisations to maximise big data analytic insights to improve the treatment and outcomes of thousands of people living with chronic disease in the UK.